Clinical Trial Update: Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring losartan and nivolumab with FOLFIRINOX and SBRT for localized pancreatic cancer; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Losartan (losartan)
• nivolumab (nivolumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING